Literature DB >> 14658040

Risk factors of multiple sclerosis: a case-control study.

M Zorzon1, R Zivadinov, D Nasuelli, P Dolfini, A Bosco, A Bratina, M A Tommasi, L Locatelli, G Cazzato.   

Abstract

We assessed the risk of multiple sclerosis (MS) associated with a series of putative risk factors. We studied 140 patients (90 women) with MS (mean age, 42.1 years; SD= 10.2 years; disease duration, 10.9 years, SD= 7.5 years) and 131 sex-and age-matched controls. Using a structured questionnaire, we collected information related to demographic data, socio-economic status, education, ethnicity, changes of domiciles, migration, occupation, environmental, nutritional and hormonal factors, exposure to various bacterial and viral agents, vaccinations, and family history of diseases. In multiple logistic regression analysis, we found independent risk factors of MS to be: familiarity for MS (OR= 12.1; 95% CI, 1.3-110.7), autoimmune diseases (OR= 3.8; 95% CI, 2.0-7.1) and migraine (OR= 8.7; 95% CI, 1.0-75.4); comorbidity with autoimmune disease (OR= 6.8; 95% CI, 1.4-32.0) and migraine (OR= 13.5; 95% CI, 1.5-116.6); and vaccination against measles (OR= 92.2; 95%, 12.1-700.2). Familial susceptibility to MS, autoimmune diseases and migraine, and vaccination to measles are associated with an increased risk of MS. The data collected in this study are confirmatory and support the hypothesis that etiology of MS constitutes the effect of interplay between genetic and environmental risk factors. However, the relatively small number of cases and controls prevents firm conclusions.

Entities:  

Mesh:

Year:  2003        PMID: 14658040     DOI: 10.1007/s10072-003-0147-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  33 in total

Review 1.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Increased risk of multiple sclerosis among women with migraine in the Nurses' Health Study II.

Authors:  Ilya Kister; Kassandra L Munger; Joseph Herbert; Alberto Ascherio
Journal:  Mult Scler       Date:  2011-08-03       Impact factor: 6.312

Review 3.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

Review 4.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

5.  Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.

Authors:  R Zivadinov; B Raj; M Ramanathan; B Teter; J Durfee; M G Dwyer; N Bergsland; C Kolb; D Hojnacki; R H Benedict; B Weinstock-Guttman
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-18       Impact factor: 3.825

Review 6.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 7.  Tension-type headache and migraine in multiple sclerosis.

Authors:  Ilya Kister; Ana B Caminero; Joseph Herbert; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2010-12

8.  An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Lahiru Handunnetthi; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

Review 9.  The initiation and prevention of multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; Jan D Lünemann
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

10.  Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis.

Authors:  Fotini Pittas; Anne-Louise Ponsonby; Ingrid A F van der Mei; Bruce V Taylor; Leigh Blizzard; Patricia Groom; Obioha C Ukoumunne; Terry Dwyer
Journal:  J Neurol       Date:  2009-04-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.